Trials / Sponsors / Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Phase 1 | 2024-04-16 |
| Recruiting | P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma Multiple Myeloma | Phase 1 | 2022-05-05 |
| Active Not Recruiting | P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer | Phase 1 | 2022-02-15 |
| Terminated | P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRP Prostatic Neoplasms, Castration-Resistant, Neoplasms by Histologic Type, Neoplasms, Prostate | Phase 1 | 2020-02-28 |
| Active Not Recruiting | Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101 Multiple Myeloma | Phase 1 | 2018-10-29 |
| Terminated | P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) Multiple Myeloma | Phase 1 / Phase 2 | 2017-09-20 |